Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

ICICI Prudential Life Insurance - Q4FY21 Result Update - YES Securities

Posted On: 2021-04-20 11:09:01 (Time Zone: UTC)


Result Highlights

- NBP - NBP was at Rs 51bn growing by 23% on YoY basis which was better than our expectation. The performance was mainly supported by a jump of 23% in single premium while First year premium registered a growth of 23%.

- APE - APE at Rs 25bn was higher than our estimate of Rs 21.9bn. APE grew by 27% yoy and by 50.6% qoq. The growth was led by strong performance in saving products.

- APE Mix - Share of Non-linked savings business increased by 1103bps which was offset by decline of 687bps in share of ULIPs and 412bps in Protection.

- VNB & VNB Margin - Q4FY21 VNB at Rs 5.9bn was higher than our forecasts of Rs 5.8bn, while VNB margin at 23.6% was lower than our estimates of 26.5%. On a yoy basis VNB margins contracted by 25bps and by 214bps on sequential basis.

- Persistency improvement - Sequentially, persistency saw an improvement across all time period, however on a yoy persistency across all time period saw a decline.

- Opex and commission ratios - Cost ratios have improved with commission ratios falling 46bps yoy whereas opex ratio improved by 16bps yoy.

- Profits - PAT came at Rs 625mn, reduction on both YoY and QoQ basis.

- EV - Embedded Value grew 26.4% to Rs. 291.06 bn during the year

- Channel Mix - Mix of Agency channel increased by 167bps on YoY basis, however, saw a sharp decline of 173bps on qoq basis. On yoy basis, share of banca saw a decline.

Our view: ICICI Pru is embarking on an aggressive target of a 28% CAGR in VNB Margins during FY21-23E. The drivers for this growth include 1) Strong growth in business from non-ICICI bank partners (IndusInd Bank, AU Bank, RBL Bank, IDFC and Standard Chartered) as most of these relationships were created in fag end of the past fiscal, 2) in terms of products there is a strong focus on non-par products, which would be margin accretive, 3) no price hike in protection will enable market share gains and 4) impact of ICICI Bank change in stance is now in the base. Factoring these in, we are raising our VNB estimates for FY22E and FY23E by 8% and 11% respectively. A delivery on their aspirational target of 28% CAGR can call for a re-rating, which we have not built in our target price yet. We retain our BUY rating with a 1-year revised price target of Rs574 (from Rs562 earlier).

Shares of ICICI Prudential Life Insurance Company Ltd was last trading in BSE at Rs.478.3 as compared to the previous close of Rs. 452.25. The total number of shares traded during the day was 1507681 in over 39997 trades.

The stock hit an intraday high of Rs. 503.95 and intraday low of 462.35. The net turnover during the day was Rs. 740651842.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Maintain BUY on Federal Bank - Pristine asset quality offsets a low provisioning buffer - HDFC Securities

YES SECURITIES on Colgate Palmolive 4QFY21 results - Growth still elusive but margins keep racing ahead

SELL recommendation on Vinati Organics - Robust quarter - HDFC Securities

Maintain ADD on Colgate Palmolive - Beat on all fronts; focus on new launches' success - HDFC Securities

Maintain BUY on Oberoi Realty - Blockbuster quarter - HDFC Securities

Just Dial - Q4FY21 Result Update - YES Securities

Colgate-Palmolive (India) Ltd - Q4FY21 Result Update - YES Securities

Gland Pharma - Q4FY21 Result Update - YES Securities

Oberoi Realty Ltd - Q4FY21 Result Update - YES Securities

Bharti Airtel - Q4 FY21 First cut: Inline - YES Securities

Colgate Palmolive (India) - More of the same - ICICI Securities

Federal Bank - Steady asset quality despite challenges - ICICI Securities

Rossari Biotech - Inorganic growth is key to watch - ICICI Securities

Garden Reach Shipbuilders & Engineers - Execution pickup expected in FY22E - ICICI Securities

Mindspace Business Parks REIT - Q4FY21 - Near-term weakness to persist - ICICI Securities

Oberoi Realty - New launches drive record sales bookings - ICICI Securities

Q4FY21 Company Update - Gokaldas Exports - ICICI Direct

Q4FY21 Result Update - Oberoi Realty - ICICI Direct

Q4FY21 Result Update - Federal Bank - ICICI Direct

Bharti Airtel - Q4FY21 First Cut - ICICI Direct

Maintain BUY on Cipla - Weak quarter, outlook promising - HDFC Securities

Maintain BUY on Larsen & Toubro - Growth returns - HDFC Securities

Escorts - Lowered demand guidance - HDFC Securities

Maintain ADD on Dr. Reddy's Labs - Sputnik V launch to lift near-term outlook - HDFC Securities

AU Small Finance Bank - Showcasing liability strength - cuts SA rate - ICICI Securities

Indigo Paints - The investments thesis is (nearly) intact - ICICI Securities

Greenpanel Industries - Strong growth momentum sustains - ICICI Securities

Aditya Birla Capital - Operating performance gathers momentum; company poised for RoE improvement - ICICI Securities

Dr. Reddy's Laboratories - Steady quarter; outlook intact - ICICI Securities

Cipla - Weak Q4; on track to sustain higher margins - ICICI Securities

Larsen & Toubro - Focus on margins and asset liquidation - ICICI Securities

Voltas - Q4FY21 Result Update - YES Securities

Mphasis - Q4FY21 Result Update - YES Securities

Dr Reddy's Laboratories - Q4FY21 Result Update - YES Securities

Sagar Cements Ltd - Q4FY21 Result Update - YES Securities

Greenpanel Industries Ltd - Q4FY21 Result Update - YES Securities

Larsen & Toubro Ltd - Q4FY21 Result Update - YES Securities

Balkrishna Industries - Growth momentum accelerates - ICICI Securities

Voltas - Healthy growth, uncertain outlook - ICICI Securities

Vedanta - Aluminium, Zinc India continue to drive earnings - ICICI Securities

Q4FY21 Result Update - SKF India - ICICI Direct

Q4FY21 Result Update - Sagar Cements - ICICI Direct

Q4FY21 Result Update - Dr Reddy's Laboratories - ICICI Direct

Q4FY21 Result Update - Dwarikesh Sugar - ICICI Direct

Q4FY21 Result Update - Indian Energy Exchange - ICICI Direct

Q4FY21 Result Update - Balkrishna Industries - ICICI Direct

Q4FY21 Result Update - Avadh Sugar & Energy - ICICI Direct

Q4FY21 Company Update - Vardhman Special Steel - ICICI Direct

Q4FY21 Result Update - Cipla Ltd - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020